Clinical Trial Update: To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Sunpharma1505 versus Reference1505 in active rheumatoid arthritis was terminated with posted results in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Reference1505
• Sunpharma1505

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Active Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2019-11-21